- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01819025
Cognitive Behavioral Therapy Treatment of Depression With Smartphone Support
Face-to-face CBT Treatment of Depression With Smartphone Support
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mild to moderate depression is a major health problem, which lowers the quality of life for the individual and generates enormous costs for society. Several forms of psychotherapy have been found to be effective in the treatment of depression. Among these, behavioral activation has a strong empirical base. The efficacy of behavioral activation for treating major depressive disorders has been established in a number of studies over the last four decades.
Moreover face-to-face treatments could benefit from using smartphones as an adjunct to the regular sessions, which in the case of behavioral activation treatments for depression could facilitate activity scheduling and homework, which are crucial elements of the treatment. It may also be possible to reduce the number of sessions.
Since it has been shown that full behavioral activation is an effective treatment for mild to moderate depression, this study will be designed as a so-called non-inferiority study in which the treatment group, given fewer meetings face-to-face, but instead support in the form of a smartphone application. Instead of a traditional behavioral activation treatment of 10 sessions, the treatment group will be given four face-to-face CBT sessions and a smartphone app as a complement and support to the four sessions. As a control, the investigators will give full behavioral activation with 10 sessions of face-to-face therapy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden
- Linköping University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- depressive symptoms according to DSM-IV
- have access to a smartphone and to the Internet
- have good knowledge of the Swedish language
Exclusion Criteria:
- recent (during last 6 weeks) change in psychiatric medication
- presently in any other psychological treatment
- severe depression
- suicidal ideation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 4 face-to-face and smartphone-app
Four face-to-face therapy sessions and smartphone app as a complement and support to the four sessions.
|
An 8 week blended therapy with both face-to-face therapy sessions and support through a smartphone application.
|
|
Active Comparator: TAU
10 sessions of face-to-face therapy, full behavioral activation
|
10 sessions of face-to-face therapy, full behavioral activation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Beck Depression Inventory (BDI)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life Inventory (QOLI)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Acceptance & Action Questionnaire (AAQ)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Beck Anxiety Inventory (BAI)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P)- Change from baseline
Time Frame: Two weeks pre treatment and at six months post treatment.
|
Change from baseline in health cost burden and at six months post treatment.
|
Two weeks pre treatment and at six months post treatment.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GA-PC-HH-KHL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on 4 face-to-face therapy session and a smartphone-app
-
Universidad Complutense de MadridFUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO SAN CARLOSCompleted
-
Charite University, Berlin, GermanyDeutscher Akademischer Austausch Dienst; Swinburne University of TechnologyRecruiting
-
University of Wisconsin, MadisonCompletedObesity | Overweight | ChildUnited States
-
Instituto Médico Tecnológico SLRAPbarcelonaRecruitingMenopause | Dyspareunia | Genitourinary Syndrome of MenopauseSpain
-
Maimónides Biomedical Research Institute of CórdobaUniversidad de CórdobaActive, not recruiting
-
PfizerCompleted
-
Tampere University HospitalNot yet recruitingPalliative Care | Breathlessness
-
Qatar UniversityHamad Medical CorporationCompleted
-
Tampere University HospitalCompleted
-
Hebrew University of JerusalemHadassah Medical OrganizationRecruiting